{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T08:51:12Z","timestamp":1762505472913,"version":"3.44.0"},"reference-count":40,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2009,4,1]],"date-time":"2009-04-01T00:00:00Z","timestamp":1238544000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2009,4,1]],"date-time":"2009-04-01T00:00:00Z","timestamp":1238544000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["cancergeneticsjournal.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Genetics and Cytogenetics"],"published-print":{"date-parts":[[2009,4]]},"DOI":"10.1016\/j.cancergencyto.2009.01.006","type":"journal-article","created":{"date-parts":[[2009,4,20]],"date-time":"2009-04-20T04:36:16Z","timestamp":1240202176000},"page":"97-100","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"title":["Acute myeloid leukemia and diabetes insipidus with monosomy 7"],"prefix":"10.1016","volume":"190","author":[{"given":"Antoine","family":"Harb","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Tan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gregory E.","family":"Wilding","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Minoo","family":"Battiwalla","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sheila N.J.","family":"Sait","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eunice S.","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meir","family":"Wetzler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.cancergencyto.2009.01.006_bib1","first-page":"801","article-title":"Aberrant phenotypes in acute myeloid leukemia: a high frequency and its clinical significance","volume":"86","author":"Bahia","year":"2001","journal-title":"Haematologica"},{"key":"10.1016\/j.cancergencyto.2009.01.006_bib2","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1111\/j.1600-0609.1987.tb01447.x","article-title":"Monosomy 7 predisposes to diabetes insipidus in leukaemia and myelodysplastic syndrome","volume":"39","author":"de la Chapelle","year":"1987","journal-title":"Eur J Haematol"},{"key":"10.1016\/j.cancergencyto.2009.01.006_bib3","doi-asserted-by":"crossref","first-page":"4791","DOI":"10.1200\/JCO.2008.16.0259","article-title":"Monosomal karyotype in acute myeloid leukemia: a better indicator of poor prognosis than a complex karyotype","volume":"26","author":"Breems","year":"2008","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.cancergencyto.2009.01.006_bib4","first-page":"322a","article-title":"High-dose cytarabine and idarubicin induction produces a high complete remission rate in previously untreated de novo acute myeloid leukemia patients","volume":"96","author":"Baer","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.cancergencyto.2009.01.006_bib5","first-page":"569","article-title":"Targeting signal transducer and activator or transcription 3 protein with arsenic trioxide: a phase I clinical trial","volume":"23","author":"Wetzler","year":"2005","journal-title":"Proc Am Soc Clin Oncol"},{"key":"10.1016\/j.cancergencyto.2009.01.006_bib6","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1182\/blood.V76.3.473.473","article-title":"High-dose etoposide and cyclophosphamide without bone marrow transplantation for resistant hematologic malignancy","volume":"76","author":"Brown","year":"1990","journal-title":"Blood"},{"key":"10.1016\/j.cancergencyto.2009.01.006_bib7","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1016\/j.leukres.2004.01.009","article-title":"First experience with gemtuzumab ozogamicin plus cytarabine as continuous infusion for elderly acute myeloid leukaemia patients","volume":"28","author":"Piccaluga","year":"2004","journal-title":"Leuk Res"},{"key":"10.1016\/j.cancergencyto.2009.01.006_bib8","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1016\/j.bbmt.2006.11.024","article-title":"Allogeneic hematopoietic stem cell transplantation for the treatment of high-risk acute myelogenous leukemia and myelodysplastic syndrome using reduced-intensity conditioning with fludarabine and melphalan","volume":"13","author":"Oran","year":"2007","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.cancergencyto.2009.01.006_bib9","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1111\/j.1600-0609.1984.tb00689.x","article-title":"Diabetes insipidus in preleukaemic phase of acute myeloid leukaemia in 2 patients with empty sella turcica. A report of 2 cases","volume":"32","author":"Puolakka","year":"1984","journal-title":"Scand J Haematol"},{"key":"10.1016\/j.cancergencyto.2009.01.006_bib10","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1002\/hon.2900100313","article-title":"Acute myelogenous leukemia (AML) and diabetes insipidus (DI): further association with monosomy 7","volume":"10","author":"Slater","year":"1992","journal-title":"Hematol Oncol"},{"key":"10.1016\/j.cancergencyto.2009.01.006_bib11","first-page":"175","article-title":"Recovery from diabetes insipidus associated with AML after a BMT conditioning regimen including busulfan","volume":"11","author":"Pagano","year":"1993","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.cancergencyto.2009.01.006_bib12","doi-asserted-by":"crossref","first-page":"111","DOI":"10.3109\/08880019409141908","article-title":"Monosomy 7, diabetes insipidus and acute myeloid leukemia in childhood","volume":"11","author":"Kanabar","year":"1994","journal-title":"Pediatr Hematol Oncol"},{"key":"10.1016\/j.cancergencyto.2009.01.006_bib13","first-page":"356","article-title":"3q aberration and monosomy 7 in ANLL presenting with high platelet count and diabetes insipidus","volume":"79","author":"La Starza","year":"1994","journal-title":"Haematologica"},{"key":"10.1016\/j.cancergencyto.2009.01.006_bib14","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000204080","article-title":"Acute myeloid leukemia and diabetes insipidus: results in 5 patients","volume":"93","author":"Castagnola","year":"1995","journal-title":"Acta Haematol"},{"key":"10.1016\/j.cancergencyto.2009.01.006_bib15","first-page":"116","article-title":"Diabetes insipidus, acute myelogenous leukemia, and monosomy 7","volume":"96","author":"Mozersky","year":"1996","journal-title":"J Am Osteopath Assoc"},{"key":"10.1016\/j.cancergencyto.2009.01.006_bib16","first-page":"129","article-title":"Acute myeloid leukemia with monosomy 7 accompanied by central diabetes insipidus","volume":"38","author":"Kawano","year":"1997","journal-title":"Japan J Clin Hematol"},{"key":"10.1016\/j.cancergencyto.2009.01.006_bib17","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1097\/00043426-200009000-00015","article-title":"Diabetes insipidus as a presenting symptom of acute myelogenous leukemia","volume":"22","author":"Frangoul","year":"2000","journal-title":"J Pediatr Hematol Oncol"},{"key":"10.1016\/j.cancergencyto.2009.01.006_bib18","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/S0300-2977(99)00110-2","article-title":"Central diabetes insipidus preceding acute myeloid leukemia with t(3;12)(q26;p12)","volume":"56","author":"Nieboer","year":"2000","journal-title":"Neth J Med"},{"key":"10.1016\/j.cancergencyto.2009.01.006_bib19","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1034\/j.1600-0609.2001.00346.x","article-title":"Diabetes insipidus revealing acute myelogenous leukaemia with a high platelet count, monosomy 7 and abnormalities of chromosome 3: a new entity?","volume":"66","author":"Lavabre-Bertrand","year":"2001","journal-title":"Eur J Haematol"},{"key":"10.1016\/j.cancergencyto.2009.01.006_bib20","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1046\/j.1365-2141.2002.03727.x","article-title":"Diabetes insipidus as first manifestation of acute myeloid leukaemia with EVI-1-positive, 3q21q26 syndrome and T cell-line antigen expression: what is the EVI-1 gene role?","volume":"118","author":"Breccia","year":"2002","journal-title":"Br J\u00a0Haematol"},{"key":"10.1016\/j.cancergencyto.2009.01.006_bib21","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/S0165-4608(02)00521-6","article-title":"Central diabetes insipidus and inv(3)(q21q26) and monosomy 7 in acute myeloid leukemia","volume":"136","author":"Keung","year":"2002","journal-title":"Cancer Genet Cytogenet"},{"key":"10.1016\/j.cancergencyto.2009.01.006_bib22","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1034\/j.1600-0609.2002.02763.x","article-title":"Myelodysplastic syndrome in transformation to acute myeloid leukemia presenting with diabetes insipidus: due to pituitary infiltration association with abnormalities of chromosomes 3 and 7","volume":"69","author":"Muller","year":"2002","journal-title":"Eur J Haematol"},{"key":"10.1016\/j.cancergencyto.2009.01.006_bib23","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1007\/s00431-001-0897-1","article-title":"Acute myeloid leukemia presenting with diabetes insipidus","volume":"161","author":"Wossmann","year":"2002","journal-title":"Eur J Pediatr"},{"key":"10.1016\/j.cancergencyto.2009.01.006_bib24","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1007\/s00277-003-0782-2","article-title":"High-risk AML complicated by pulmonary aspergillosis: successful treatment with nonmyeloablative stem cell transplantation and long-term administration of voriconazole","volume":"83","author":"Eibl","year":"2004","journal-title":"Ann Hematol"},{"key":"10.1016\/j.cancergencyto.2009.01.006_bib25","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1002\/ajh.20522","article-title":"Diabetes insipidus and thrombocytosis as the presenting symptoms of acute myeloblastic leukemia with monosomy 7","volume":"81","author":"Otrock","year":"2006","journal-title":"Am J Hematol"},{"key":"10.1016\/j.cancergencyto.2009.01.006_bib26","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1016\/j.leukres.2006.11.008","article-title":"Erythroleukaemia, diabetes insipidus and hypophyseal damage: two case reports","volume":"31","author":"Piccin","year":"2007","journal-title":"Leuk Res"},{"key":"10.1016\/j.cancergencyto.2009.01.006_bib27","unstructured":"Mitelman F: Mitelman database of chromosome aberrations in cancer, 2008. Available at: http:\/\/cgap.ncl.nih.gov\/chromosomes\/Mitelman. Accessed December 23, 2008."},{"key":"10.1016\/j.cancergencyto.2009.01.006_bib28","first-page":"690","article-title":"3q21 and 3q26 cytogenetic abnormalities in acute myeloblastic leukemia: biological and clinical features","volume":"84","author":"Testoni","year":"1999","journal-title":"Haematologica"},{"key":"10.1016\/j.cancergencyto.2009.01.006_bib29","first-page":"183","article-title":"Structurally altered Evi-1 protein generated in the 3q21q26 syndrome","volume":"13","author":"Ogawa","year":"1996","journal-title":"Oncogene"},{"key":"10.1016\/j.cancergencyto.2009.01.006_bib30","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1038\/sj.leu.2400584","article-title":"The leukemia-associated gene MDS1\/EVI1 is a new type of GATA-binding transactivator","volume":"11","author":"Soderholm","year":"1997","journal-title":"Leukemia"},{"key":"10.1016\/j.cancergencyto.2009.01.006_bib31","doi-asserted-by":"crossref","first-page":"3937","DOI":"10.1073\/pnas.89.9.3937","article-title":"Activation of EVI1 gene expression in human acute myelogenous leukemias by translocations spanning 300-400 kilobases on chromosome band 3q26","volume":"89","author":"Morishita","year":"1992","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.cancergencyto.2009.01.006_bib32","first-page":"1221","article-title":"Association of 3q21q26 syndrome with different RPN1\/EVI1 fusion transcripts","volume":"88","author":"Martinelli","year":"2003","journal-title":"Haematologica"},{"key":"10.1016\/j.cancergencyto.2009.01.006_bib33","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/S0145-2126(00)00031-X","article-title":"The EVI-1 gene\u2013its role in pathogenesis of human leukemias","volume":"24","author":"Jolkowska","year":"2000","journal-title":"Leuk Res"},{"key":"10.1016\/j.cancergencyto.2009.01.006_bib34","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1111\/j.1365-2265.1986.tb01648.x","article-title":"Human platelet arginine vasopressin","volume":"24","author":"Nussey","year":"1986","journal-title":"Clin Endocrinol"},{"key":"10.1016\/j.cancergencyto.2009.01.006_bib35","doi-asserted-by":"crossref","first-page":"657","DOI":"10.3109\/10428199809057578","article-title":"Acute myeloblastic leukemia associated with hyperleukocytosis and diabetes insipidus","volume":"30","author":"Dilek","year":"1998","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.cancergencyto.2009.01.006_bib36","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1038\/bjc.1995.85","article-title":"Cancer incidence in men with Klinefelter syndrome","volume":"71","author":"Hasle","year":"1995","journal-title":"Br J Cancer"},{"key":"10.1016\/j.cancergencyto.2009.01.006_bib37","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/0165-4608(87)90073-2","article-title":"Klinefelter's syndrome and acute leukemia","volume":"26","author":"Horsman","year":"1987","journal-title":"Cancer Genet Cytogenet"},{"key":"10.1016\/j.cancergencyto.2009.01.006_bib38","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1016\/S0140-6736(80)91539-1","article-title":"Klinefelter syndrome: predisposition to acute non-lymphocytic leukaemia?","volume":"1","author":"Geraedts","year":"1980","journal-title":"Lancet"},{"key":"10.1016\/j.cancergencyto.2009.01.006_bib39","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/S0140-6736(61)92712-X","article-title":"Acute leukaemia and Klinefelter's syndrome","volume":"2","author":"Mamunes","year":"1961","journal-title":"Lancet"},{"key":"10.1016\/j.cancergencyto.2009.01.006_bib40","doi-asserted-by":"crossref","first-page":"4325","DOI":"10.1182\/blood-2002-03-0772","article-title":"Pretreatment cytogenetic abnormalities are predictive of induction success, cumulative incidence of relapse, and overall survival in adult patients with de novo acute myeloid leukemia: results from Cancer and Leukemia Group B (CALGB 8461)","volume":"100","author":"Byrd","year":"2002","journal-title":"Blood"}],"container-title":["Cancer Genetics and Cytogenetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165460809000454?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165460809000454?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T07:49:21Z","timestamp":1759045761000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165460809000454"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,4]]},"references-count":40,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2009,4]]}},"alternative-id":["S0165460809000454"],"URL":"https:\/\/doi.org\/10.1016\/j.cancergencyto.2009.01.006","relation":{},"ISSN":["0165-4608"],"issn-type":[{"type":"print","value":"0165-4608"}],"subject":[],"published":{"date-parts":[[2009,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Acute myeloid leukemia and diabetes insipidus with monosomy 7","name":"articletitle","label":"Article Title"},{"value":"Cancer Genetics and Cytogenetics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cancergencyto.2009.01.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2009 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}